UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000054139
Receipt number R000061819
Scientific Title A before-and-after comparative study of the effects of a survey on walking behavior and guidance by pharmacy pharmacists among local residents
Date of disclosure of the study information 2024/04/12
Last modified on 2024/04/12 21:49:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A before-and-after comparative study of the effects of a survey on walking behavior and guidance by pharmacy pharmacists among local residents

Acronym

A before-and-after comparative study of the effects of a survey on walking behavior and guidance by pharmacy pharmacists among local residents

Scientific Title

A before-and-after comparative study of the effects of a survey on walking behavior and guidance by pharmacy pharmacists among local residents

Scientific Title:Acronym

A before-and-after comparative study of the effects of a survey on walking behavior and guidance by pharmacy pharmacists among local residents

Region

Japan


Condition

Condition

None

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study was to investigate the actual state of walking of local residents, and to compare the effect of improving walking by pharmacy pharmacists before and after guidance.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Overall score of average acceleration with safety walk navigation system

Key secondary outcomes

Score of the walking guidance check sheet
Average acceleration and score of up/down, left/right front by safety walk navigation system


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

walking instruction

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

Persons who have obtained the subject's written consent to participate in this study.

Key exclusion criteria

eople with hypersensitivity to the materials in the Walking Impact Analysis System (Safety Walk Navi) and the rise test box.
People with pain, swelling, inflammation, injury, or paralysis of the lower limbs and with limited ambulation.
People who cannot be fitted with the Safety Walk Navi device.
Persons who are otherwise deemed unsuitable as subjects by the principal investigator.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Chigusa
Middle name
Last name Kikuchi

Organization

Showa Pharmaceutical University

Division name

Showa Pharmaceutical University

Zip code

1948543

Address

3-3165 Higashi-Tamagawa Gakuen, Machida, Tokyo

TEL

+81-42-721-1535

Email

c-kikuchi@ac.shoyaku.ac.jp


Public contact

Name of contact person

1st name Chigusa
Middle name
Last name Kikuchi

Organization

Showa Pharmaceutical University

Division name

Department of Community Medicine, Center for Clinical Pharmacy Education and Research

Zip code

1948543

Address

3-3165 Higashi-Tamagawa Gakuen, Machida, Tokyo

TEL

+81-42-721-153

Homepage URL


Email

c-kikuchi@ac.shoyaku.ac.jp


Sponsor or person

Institute

Showa Pharmaceutical University

Institute

Department

Personal name



Funding Source

Organization

Showa Pharmaceutical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Showa Pharmaceutical University Ethics Review Committee

Address

3-3165 Higashi-Tamagawa Gakuen, Machida, Tokyo

Tel

+081-42-721-1511

Email

shomu@ad.shoyaku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 04 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 03 Month 06 Day

Date of IRB

2024 Year 03 Month 06 Day

Anticipated trial start date

2024 Year 04 Month 13 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 04 Month 12 Day

Last modified on

2024 Year 04 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061819


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name